Sugi Predict

Sugi Predict / Compounds / SCHEMBL559468

SCHEMBL559468

SCHEMBL559468

CC(=O)C(C)CCCCCCC(=O)O

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ FFAR4 Q5NUL3 2/20 0.57
▸ FFAR1 O14842 2/20 0.57
▸ TSHR P16473 5/20 0.52
▸ LMNA P02545 1/20 0.52
▸ NFKB1 P19838 1/20 0.52
▸ PMP22 Q01453 1/20 0.52
▸ ALDH1A1 P00352 3/20 0.50
▸ GSTK1 Q9Y2Q3 1/20 0.48
▸ GPR84 Q9NQS5 7/20 0.48
▸ PPARG P37231 6/20 0.48
▸ PPARD Q03181 6/20 0.48
▸ PPARA Q07869 6/20 0.48
▸ HDAC11 Q96DB2 5/20 0.48
▸ TLR2 O60603 2/20 0.48
▸ TDP1 Q9NUW8 2/20 0.48
▸ FABP4 P15090 2/20 0.48
▸ PTPN1 P18031 2/20 0.48
▸ SLC22A6 Q4U2R8 1/20 0.48
▸ SLC22A8 Q8TCC7 1/20 0.48
▸ MEN1 O00255 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14093813 1.00 FFAR4 (0.57) FFAR4FFAR1TSHRLMNANFKB1
SCHEMBL304217 1.00 FFAR4 (0.57) FFAR4FFAR1TSHRLMNANFKB1
SCHEMBL999059 0.98 FFAR4 (0.53) FFAR4FFAR1TSHRLMNANFKB1
SCHEMBL28041784 0.94 FFAR4 (0.52) FFAR4FFAR1TSHRLMNANFKB1
SCHEMBL10068076 0.91 CYP1A2 (0.50) FFAR4FFAR1TSHRLMNANFKB1
SCHEMBL2348647 0.91 CYP1A2 (0.50) FFAR4FFAR1TSHRLMNANFKB1
SCHEMBL12153332 0.86 CA1 (0.46) FFAR4FFAR1GPR84
SCHEMBL21998 0.84 CYP1A2 (0.67) FFAR4FFAR1TSHRLMNANFKB1
SCHEMBL3811423 0.84 CYP1A2 (0.67) FFAR4FFAR1TSHRLMNANFKB1
SCHEMBL11884635 0.84 PAOX (0.48) FFAR4FFAR1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 29 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-118027702-A Dye with up-conversion performance, and synthetic method and application thereof 大连理工大学 2024-05-14 — — CN disclosed
EP-2850061-B1 HALOGENATED INDOLE DERIVATIVES FOR PHOTODYNAMIC THERAPY NANOQUANTUM SCIENCES INC (US) 2020-09-16 — — EP disclosed
US-9572881-B2 Halogenated compounds for photodynamic therapy NANOQUANTUM SCIENCES, INC. (US) 2017-02-21 — — US disclosed
US-20150335745-A1 HALOGENATED COMPOUNDS FOR PHOTODYNAMIC THERAPY NANOQUANTUM SCIENCES, INC. (US) 2015-11-26 — — US disclosed
US-9110069-B2 Luminescent compounds SETA BIOMEDICALS, LLC (US) 2015-08-18 — — US disclosed
US-9095612-B2 Halogenated compounds for photodynamic therapy NANOQUANTUM SCIENCES, INC. (US) 2015-08-04 — — US disclosed
US-9040721-B2 Halogenated compounds for Photodynamic therapy NANOQUANTUM SCIENCES, INC. (US) 2015-05-26 — — US disclosed
EP-2850061-A2 HALOGENATED COMPOUNDS FOR PHOTODYNAMIC THERAPY Nanoquantum Sciences Inc. (US) 2015-03-25 — — EP disclosed
US-8962797-B2 Halogenated compounds for photodynamic therapy NANOQUANTUM SCIENCES, INC. (US) 2015-02-24 — — US disclosed
US-20140296511-A1 HALOGENATED COMPOUNDS FOR PHOTODYNAMIC THERAPY NANOQUANTUM SCIENCES, INC. (US) 2014-10-02 — — US disclosed
US-20120035346-A1 LUMINESCENT COMPOUNDS SETA BIOMEDICALS, LLC 2012-02-09 — — US disclosed
US-20100266507-A1 LUMINESCENT COMPOUNDS SETA BIOMEDICALS, LLC 2010-10-21 — — US disclosed
WO-2010083471-A1 LUMINESCENT COMPOUNDS SETA BIOMEDICALS, LLC (US) 2010-07-22 — — WO disclosed
EP-2129788-A2 LUMINESCENT COMPOUNDS Seta Biomedicals, LLC (US) 2009-12-09 — — EP disclosed
US-7411068-B2 Luminescent compounds SETA BIOMEDICALS, LLC 2008-08-12 — — US disclosed
WO-2008094637-A2 LUMINESCENT COMPOUNDS SETA BIOMEDICALS. LLC (US) 2008-08-07 — — WO disclosed
US-20070281363-A1 Reporter molecules based on squaric, croconic, and/or rhodizonic acid; photoluminescence Terpetschnig, Ewald (US) 2007-12-06 — — US disclosed
US-7250517-B2 Luminescent compounds Terpetschnig, Ewald A. (US) 2007-07-31 — — US disclosed
US-20050202565-A1 Luminescent compounds SETA BIOMEDICALS, LLC 2005-09-15 — — US disclosed
US-20040166515-A1 Luminescent compounds TERPETSCHNIG, EWALD A. 2004-08-26 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100266507-A1 LUMINESCENT COMPOUNDS SQLE, COASY, ZKSCAN2 FFAR4 3671/4885FFAR1 3278/4885TSHR 3692/4885
US-20150335745-A1 HALOGENATED COMPOUNDS FOR PHOTODYNAMIC THERAPY PNMT, PBRM1, PAICS FFAR4 1786/4885FFAR1 2823/4885TSHR 347/4885
US-20120035346-A1 LUMINESCENT COMPOUNDS PHOSPHO1, PGLS, PFAS FFAR4 3083/4885FFAR1 4037/4885TSHR 4660/4885
US-20140296511-A1 HALOGENATED COMPOUNDS FOR PHOTODYNAMIC THERAPY PNMT, PBRM1, PAICS FFAR4 1786/4885FFAR1 2823/4885TSHR 347/4885
US-20040166515-A1 Luminescent compounds RORC, NR2E3, RORB FFAR4 2371/4885FFAR1 1830/4885TSHR 1543/4885
US-20070281363-A1 Reporter molecules based on squaric, croconic, and/or rhodizonic acid; photoluminescence SPR, SRRT, SQLE FFAR4 3229/4885FFAR1 2447/4885TSHR 3974/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.